Pledge Therapeutics

Pledge Therapeutics efforts have given rise to a constellation of exciting discoveries, spanning from early drug hits to preclinical candidates. Our success is based on the rapid translation of clinical and disease insights into target identification and development of novel drug molecules. At the core of our effort is the integration of structural and biophysical knowledge of disease targets to accelerate the pace and success of drug development

Pledge therapeutics operates in the Biotechnology research industry.

Pledge therapeutics's revenue is 11m - 100m

Pledge therapeutics has 11 - 50 employees.